0001437749-24-021022.txt : 20240621
0001437749-24-021022.hdr.sgml : 20240621
20240621212520
ACCESSION NUMBER: 0001437749-24-021022
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240618
FILED AS OF DATE: 20240621
DATE AS OF CHANGE: 20240621
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stuglik Brian M
CENTRAL INDEX KEY: 0001716328
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35703
FILM NUMBER: 241061851
MAIL ADDRESS:
STREET 1: C/O VERASTEM, INC.
STREET 2: 117
CITY: NEEDHAM
STATE: MA
ZIP: 02494
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PUMA BIOTECHNOLOGY, INC.
CENTRAL INDEX KEY: 0001401667
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 770683487
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10880 WILSHIRE BLVD.
STREET 2: SUITE 2150
CITY: LOS ANGELES
STATE: CA
ZIP: 90024
BUSINESS PHONE: (424) 248-6500
MAIL ADDRESS:
STREET 1: 10880 WILSHIRE BLVD.
STREET 2: SUITE 2150
CITY: LOS ANGELES
STATE: CA
ZIP: 90024
FORMER COMPANY:
FORMER CONFORMED NAME: INNOVATIVE ACQUISITIONS CORP
DATE OF NAME CHANGE: 20070601
4
1
rdgdoc.xml
FORM 4
X0508
4
2024-06-18
0001401667
PUMA BIOTECHNOLOGY, INC.
PBYI
0001716328
Stuglik Brian M
C/O PUMA BIOTECHNOLOGY, INC.
10880 WILSHIRE BOULEVARD, SUITE 2150
LOS ANGELES
CA
90024
1
0
Common Stock
2024-06-18
4
A
0
27000
0
A
76058
D
Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer.
/s/ Gordon Esplin as attorney-in-fact for Brian M. Stuglik
2024-06-21